IMARC Group, a leading market research company, has recently releases report titled “Liver Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global liver disease treatment market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How Big is the Liver Disease Treatment Market?
The global liver disease treatment market size reached US$ 22.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.0 Billion by 2028, exhibiting a growth rate (CAGR) of 6.43% during 2023-2028.
What is Liver Disease Treatment?
Liver disease treatment refers to the diagnosis and cure of a wide variety of complications associated with the liver, which has led to liver failure or requires a transplant. It comprises various forms of lifestyle changes, such as limiting alcohol, maintaining a moderate weight, consuming fewer fatty and more fiber-rich food products, drinking more water, and adopting a liver-friendly diet devoid of refined sugar. It also involves taking medications, such as anti-viral drugs to treat hepatitis, steroids to lower liver inflammation, and blood pressure medicines to maintain normal blood pressure. Liver disease treatment is initiated by conducting a complete liver function test, a complete blood count test, computed tomography (CT) scan, magnetic resonance imaging (MRI), and ultrasounds to check the condition of liver damage or tumors. It also involves conducting a liver biopsy, where a small sample of live tissue is removed to examine the signs of damage or infection. It is essential for preventing a wide variety of liver conditions, such as hepatitis, fatty liver disease, hemochromatosis, Wilson’s disease, and alpha-1 antitrypsin deficiency. It is also employed for managing the effects of various autoimmune conditions which trigger the immune system to mistakenly attack healthy cells in the body, such as autoimmune hepatitis, primary biliary cirrhosis (PBC), and primary sclerosing cholangitis.
Request Free Sample Copy of This Report: https://www.imarcgroup.com/liver-disease-treatment-market/requestsample
What are the growth prospects and trends in the liver disease treatment industry?
At present, the increasing demand for liver disease treatment due to the rising occurrence of liver cancer or cirrhosis represents one of the primary factors influencing the market positively. Besides this, there is a rise in the number of alcohol addiction cases due to the rising consumption of alcohol to cope with stress, anxiety, and depression around the world. This, coupled with the growing adoption of a sedentary lifestyle and unhealthy dietary habits, is offering a favorable market outlook.
In addition, the increasing construction of hospitals, nursing homes, and clinics, along with the rising advancements in the field of medicine to improve the treatment and diagnosis of various chronic liver diseases, is propelling the growth of the market. Apart from this, the increasing number of initiatives taken by governing agencies of various countries to educate individuals about the prevention, treatment, and cure of liver diseases is contributing to the growth of the market.
Additionally, the rising awareness about the necessities of living a healthy life and taking medical assistance to prevent the symptoms of liver cancer and other complications damaging the liver is supporting the growth of the market. Moreover, the increasing research activities to develop potent anti-viral drugs, vaccines, and therapeutics for liver disease treatment are strengthening the growth of the market.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Treatment Type:
- Antiviral Drugs
- Immunosuppressants
- Vaccines
- Immunoglobulins
- Corticosteroids
- Targeted Therapy
- Chemotherapy
Breakup by Disease Type:
- Hepatitis
- Autoimmune Diseases
- Non-alcoholic Fatty Liver Disease (NAFLD)
- Cancer
- Genetic Disorders
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Abbott Laboratories
- AbbVie Inc.
- Astellas Pharma Inc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Emergent BioSolutions Inc.
- F. Hoffmann-La Roche AG
- Gilead Sciences Inc.
- GlaxoSmithKline plc
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
- Viatris Inc.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5023&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: [email protected]
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
The post Liver Disease Treatment Market Size & Industry Report 2023-2028 appeared first on Washington Post News.
